These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 29198713

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Prophylactic and therapeutic vaccines for Japanese cedar pollinosis].
    Ishii Y.
    Nihon Yakurigaku Zasshi; 2010 Jun; 135(6):250-3. PubMed ID: 20543516
    [No Abstract] [Full Text] [Related]

  • 5. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
    Osada T, Tanaka Y, Yamada A, Sasaki E, Utsugi T.
    Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489
    [Abstract] [Full Text] [Related]

  • 6. Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress.
    Yonekura S, Gotoh M, Okano M, Kurokawa T, Maekawa Y, Okubo K, Okamoto Y.
    Allergol Int; 2022 Jan; 71(1):140-143. PubMed ID: 34509370
    [No Abstract] [Full Text] [Related]

  • 7. Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys.
    Fujimura T, Fujinami K, Ishikawa R, Tateno M, Tahara Y, Okumura Y, Ohta H, Miyazaki H, Taniguchi M.
    Int Arch Allergy Immunol; 2015 Jan; 168(1):32-43. PubMed ID: 26524293
    [Abstract] [Full Text] [Related]

  • 8. Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Birch Pollen Preparation.
    Buczyłko K, van der Werf JF, Boot D, van Ree R.
    Int Arch Allergy Immunol; 2017 Jan; 172(3):183-186. PubMed ID: 28380494
    [Abstract] [Full Text] [Related]

  • 9. Ultra-short-course booster allergen immunotherapy.
    Pfaar O, Pieper-Fürst U, Mösges R.
    Immunotherapy; 2018 Jun; 10(7):525-528. PubMed ID: 29562789
    [No Abstract] [Full Text] [Related]

  • 10. [A novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy].
    Tofukuji S, Ishida S, Katayama K.
    Nihon Yakurigaku Zasshi; 2017 Jun; 150(2):68-71. PubMed ID: 28794300
    [No Abstract] [Full Text] [Related]

  • 11. Immunodominance in allergic T-cell reactivity to Japanese cedar in different geographic cohorts.
    Oseroff C, Pham J, Frazier A, Hinz D, Sidney J, Paul S, Greenbaum JA, Vita R, Peters B, Schulten V, Sette A.
    Ann Allergy Asthma Immunol; 2016 Dec; 117(6):680-689.e1. PubMed ID: 27979027
    [Abstract] [Full Text] [Related]

  • 12. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T.
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Latent 1,3-β-D-glucan acts as an adjuvant for allergen-specific IgE production induced by Japanese cedar pollen exposure.
    Kanno T, Adachi Y, Ohashi-Doi K, Matsuhara H, Hiratsuka R, Ishibashi KI, Yamanaka D, Ohno N.
    Allergol Int; 2021 Jan; 70(1):105-113. PubMed ID: 32919904
    [Abstract] [Full Text] [Related]

  • 18. Formation of IgE-Allergen-CD23 Complex Changes in Children Treated with Subcutaneous Immunotherapy for Japanese Cedar Pollinosis.
    Asaumi T, Sato S, Yanagida N, Matsuhara H, Kobayashi S, Fukano C, Ohashi-Doi K, Ebisawa M.
    Int Arch Allergy Immunol; 2021 Jan; 182(3):190-194. PubMed ID: 33032294
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis.
    Wakasa Y, Takagi H, Hirose S, Yang L, Saeki M, Nishimura T, Kaminuma O, Hiroi T, Takaiwa F.
    Plant Biotechnol J; 2013 Jan; 11(1):66-76. PubMed ID: 23066780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.